Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Given Average Recommendation of "Moderate Buy" by Brokerages

Summary by marketbeat.com
Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one h

1 Articles

marketbeat.commarketbeat.com
Center

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the nine research firms that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, one h

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news on Sunday, July 5, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

South San Francisco icon

South San Francisco

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal